Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial by Leah E Cahill, Rachel A Warren, Gideon D Bahn, Allie S Carew, Andrew P Levy, John Sapp, Eric B Rimm, Peter Reaven

Connect to this object online.